Ceftazidime/Avibactam and Other Commonly Used Antibiotics Activity Against Enterobacterales and Pseudomonas aeruginosa Isolated in Poland in 2015–2019

Overview of attention for article published in Infection and Drug Resistance, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+

Article in Infection and Drug Resistance (June 2024)

Beta-lactam antibiotics in combination with novel β-lactamase inhibitors – an alternative therapy for infections caused by multidrug-resistant bacteria

Article in Pomeranian Journal of Life Sciences (March 2024)

Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Article in Journal of Global Antimicrobial Resistance (February 2024)